News | Webinars | Publications | Conferences | Upcoming Events |
-
December 4, 2017
Blue Oak & PsychoGenics Announce a Drug Discovery Partnership -
June 12, 2017
PsychoGenics Achieves a Milestone in Drug Discovery Collaboration with Sunovion -
April 4, 2016
PsychoGenics Drug Discovery Collaboration with Sunovion Achieves a Milestone -
January 27, 2016
PsychoGenics Obtains a License to the Line – 41 Mouse Model of Alzheimer’s Disease -
January 19, 2016
PsychoGenics Expands its Drug Discovery Service Capabilities -
January 12, 2016
PsychoGenics and the Alzheimer’s Drug Discovery Foundation Announce a Risk-Sharing Partnership for Preclinical Studies -
September 14, 2015
PsychoGenics Extends its Drug Discovery Collaboration with Sunovion -
August 11, 2015
PsychoGenics Obtains a License to Another Transgenic Mouse Model of α-Synucleinopathies -
March 15, 2015
PsychoGenics Obtains a License to α-synuclein Transgenic Mouse Models of Parkinson´s disease